December 23, 2024

Sugar vs. Fat: Unraveling the Metabolic Mysteries of MAIT Cells

Even though MAIT cells just make up 2 percent of the lymphocytes in the blood stream, they are quite abundant in the human body. Still, much about MAIT cell biology and medical function stays unknown.

To do this, he delivered a live bacterial vaccine pressure to a mouse design, and within days, MAIT cells had broadened 100-fold in the animals lungs. What Riffelmacher didnt anticipate to see was the development of 2 various groups of cells within this expanded population. When the researchers genetically manipulated white blood cell metabolism to favor glycolysis, MAIT1 cell numbers were elevated, verifying that metabolic process influenced the MAIT cell action.

In a new study, released in Nature Cell Biology, scientists at La Jolla Institute for Immunology (LJI) explored the area, function, gene expression, and metabolic process of MAIT cells in the mouse lung.
LJI study leaders Mitchell Kronenberg, Ph.D., (left) and Thomas Riffelmacher, Ph.D. Credit: Matthew Ellenbogen, LJI
” Metabolism is the method your cells use fuel particles to do their work,” says LJI Instructor Thomas Riffelmacher, Ph.D., first author of the study. “Theres been a recent transformation in the field in which studies are beginning to connect the function of T cells to their metabolic shows, however this had actually not yet been explored in MAIT cells.”
To leader this line of research study, Riffelmacher teamed up with LJI Professor and Chief Scientific Officer Mitchell Kronenberg, Ph.D., a professional on innate-like T cells that make more quick reactions. Their most current work identifies these residential or commercial properties in MAIT cells and how they contribute to the populations capability to combat off pathogens.
The efforts exposed 2 distinct “tastes” of MAIT cells: an antiviral subtype fueled by sugar and an anti-bacterial subtype fueled by fat. The findings might now influence novel vaccines and cell treatments that move the balance in between these 2 cell groups to help individuals fight specific pathogens.
A tale of 2 cell types
MAIT cells display boosted memory-like reactions after some infections, with greater cell numbers and stronger protective responses increasing the hosts defenses long after the pathogen has left the body. Riffelmacher at first set out to explore what molecular modifications drove this crucial memory function in MAIT cells.
To do this, he provided a live bacterial vaccine strain to a mouse design, and within days, MAIT cells had actually broadened 100-fold in the animals lungs. What Riffelmacher didnt anticipate to see was the introduction of 2 different groups of cells within this broadened population. Through a thorough set of experiments to characterize these two cell lineages, a number of distinct residential or commercial properties became clear.
One subtype of MAIT cells, predominantly situated along capillary in the lung, produced a type 1 immune response defined by the secretion of a cytokine called interferon-gamma (IFN-ɣ). These lymphocytes, called MAIT1 cells, were specialized to eliminate intracellular microbes, namely infections like influenza.
The other subtype of MAIT cells, predominantly found in lung tissue, produced a type 17 immune response defined by the secretion of a different cytokine, interleukin-17 (IL-17). MAIT17s were specialized to eliminate extracellular microbes, particularly germs like those that cause pneumonia.
To even more demonstrate their unique protective residential or commercial properties, the scientists cleansed MAIT1 and MAIT17 cells and transferred them into brand-new mice. Both populations boosted the animals resistance compared with unattended mice. Nevertheless, MAIT1s offered much better security versus the influenza virus, while MAIT17s secured versus the bacteria Streptococcus pneumoniae, the most typical reason for pneumonia.
Still more striking than their practical distinctions were their extremely divergent metabolic programs. Each cell type appeared to get its energy from a various source.
” I keep in mind seeing this first batch of information and thinking, Wow, this is a substantial difference– we need to check out this,” says Riffelmacher, who likewise serves as the LJI Immunometabolism Core Director.
MAIT1s stayed in an extremely low-energy, dormant state up until triggered, at which point they depend on sugar (glycolysis) to get their fuel. MAIT17s, on the other hand, were highly active and necessary constant consumption of fats to create adequate energy through their mitochondria. When the scientists genetically manipulated white blood cell metabolism to favor glycolysis, MAIT1 cell numbers were raised, validating that metabolism affected the MAIT cell action.
Whats the (clinical) use?
Does this mean consuming fatty foods could safeguard you versus pneumonia? Kronenberg says diet can have some influence on the distribution of metabolites in the body, but metabolism functions in a different way at the cellular and organismal levels, so theres no evidence that changing ones consuming patterns would influence MAIT cell function.
Still, by tweaking the levels of these metabolites pharmacologically, the researchers were really able to shift the animals MAIT cell reaction likely to be better at battling either a viral infection or germs.
To do this scientifically in people, the researchers suggest establishing vaccines to activate either MAIT1 or MAIT17 cells, or perhaps transplanting one cell subtype into patients to increase a specific immune reaction. Since MAIT cells and the main signaling protein they connect with are so highly saved across people and types, they are also much less most likely to trigger a graft-versus-host action than other types of white blood cells.
” Our hope is that in the future, well have tools to selectively improve MAIT1s or MAIT17s so that patients can have their body immune systems tuned against different pathogens as essential,” says Kronenberg.
Recommendation: “Divergent metabolic programmes control two populations of MAIT cells that safeguard the lung” by Thomas Riffelmacher, Mallory Paynich Murray, Chantal Wientjens, Shilpi Chandra, Viankail Cedillo-Castelán, Ting-Fang Chou, Sara McArdle, Christopher Dillingham, Jordan Devereaux, Aaron Nilsen, Simon Brunel, David M. Lewinsohn, Jeff Hasty, Gregory Seumois, Christopher A. Benedict, Pandurangan Vijayanand and Mitchell Kronenberg, 25 May 2023, Nature Cell Biology.DOI: 10.1038/ s41556-023-01152-6.
The study was funded by the National Institutes of Health and the Wellcome Trust.

Scientists have found two unique types of mucosal-associated invariant T (MAIT) cells in mouse lungs, one specialized to fight viral infections and the other to combat bacterial infections. This research may assist the development of new vaccines and cell treatments to enhance the immune system versus particular pathogens.
Researchers at the LJI have actually found that MAIT cells metabolism can be adapted to fight various pathogens, potentially leading to ingenious restorative techniques.
A non-traditional kind of leukocyte, understood as mucosal-associated invariant T (MAIT) cells, has just recently piqued the interest of both clinicians and immunologists. Unlike the traditional T cells, which are discovered circulating in our blood, MAIT cells are mainly located in tissues, offering immune security against a variety of illness.
Even though MAIT cells only comprise 2 percent of the lymphocytes in the bloodstream, they are rather abundant in the body. They comprise in between 10 and 40 percent of the lymphocytes in the liver and are regularly discovered in tissues such as the lungs. Still, much about MAIT cell biology and clinical function remains unknown.